Literature DB >> 30176218

NMDA receptors inhibit axonal outgrowth by inactivating Akt and activating GSK-3β via calcineurin in cultured immature hippocampal neurons.

Ying Wang1, Jian-Liang Tang2, Xingxing Xu3, Xin-Ping Zhou4, Jing Du5, Xin Wang5, Yi Zhou6, Qiaojuan Zhu6, Ling-Ling Yao7, Yong-Gang Wang8, Shuangxing Hou9, Zhihui Huang3.   

Abstract

Neurons are highly polarized cells with an axon and dendritic arbors. It is still not well studied that how formation and elaboration of axon and dendrites is controlled by diffusible signaling factors such as glutamate via specific receptors. We found that N-methyl-D-aspartate (NMDA) receptors were enriched (stage 2-3) but decreased expression (stage 4-5) at tip of axon of cultured hippocampal neurons during distinct development stages. Inhibition of NMDA receptor activity by competitive antagonist DL-2-amino-5-phosphonovalerate (APV) or channel blocker MK801 promoted axonal outgrowth at the early stages, whereas inhibited dendritic development in later stages. Meanwhile, knockdown of NMDA receptors also promoted axonal outgrowth and branch in immature neurons. Furthermore, GluN2B but not GluN2A subunit inhibited axonal outgrowth in immature hippocampal neurons. Finally, we found that NMDA receptors inhibited axonal outgrowth by inactivating Akt and activating GSK-3β signaling in a calcineurin-dependent manner. Taken together, our results demonstrate that stabilization GSK-3β activation in the axon growth cone by Ca2+ influx through NMDA receptors may be involved in regulation of axon formation in immature neurons at early stages.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axonal outgrowth; Calcineurin; GSK-3β; Hippocampal neurons; NMDA receptors

Mesh:

Substances:

Year:  2018        PMID: 30176218     DOI: 10.1016/j.yexcr.2018.08.033

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury.

Authors:  Yu Zhai; Shi-Yang Ye; Qiu-Shi Wang; Ren-Ping Xiong; Sheng-Yu Fu; Hao Du; Ya-Wei Xu; Yan Peng; Zhi-Zhong Huang; Nan Yang; Yan Zhao; Ya-Lei Ning; Ping Li; Yuan-Guo Zhou
Journal:  Gene Ther       Date:  2022-02-08       Impact factor: 5.250

2.  Organophosphorus flame retardants are developmental neurotoxicants in a rat primary brainsphere in vitro model.

Authors:  Helena T Hogberg; Rita de Cássia da Silveira E Sá; Andre Kleensang; Mounir Bouhifd; Ozge Cemiloglu Ulker; Lena Smirnova; Mamta Behl; Alexandra Maertens; Liang Zhao; Thomas Hartung
Journal:  Arch Toxicol       Date:  2020-10-19       Impact factor: 5.153

3.  Beyond Cholinesterase Inhibition: Developmental Neurotoxicity of Organophosphate Ester Flame Retardants and Plasticizers.

Authors:  Heather B Patisaul; Mamta Behl; Linda S Birnbaum; Arlene Blum; Miriam L Diamond; Seth Rojello Fernández; Helena T Hogberg; Carol F Kwiatkowski; Jamie D Page; Anna Soehl; Heather M Stapleton
Journal:  Environ Health Perspect       Date:  2021-10-06       Impact factor: 11.035

4.  Overexpression of Lin28A in neural progenitor cells in vivo does not lead to brain tumor formation but results in reduced spine density.

Authors:  Maximilian Middelkamp; Lisa Ruck; Christoph Krisp; Piotr Sumisławski; Behnam Mohammadi; Matthias Dottermusch; Valerie Meister; Lukas Küster; Hartmut Schlüter; Sabine Windhorst; Julia E Neumann
Journal:  Acta Neuropathol Commun       Date:  2021-11-20       Impact factor: 7.801

5.  I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway.

Authors:  Foteini Vasilopoulou; Christian Griñán-Ferré; Sergio Rodríguez-Arévalo; Andrea Bagán; Sònia Abás; Carmen Escolano; Mercè Pallàs
Journal:  Geroscience       Date:  2020-10-31       Impact factor: 7.713

6.  Serine/Threonine Phosphatases in LTP: Two B or Not to Be the Protein Synthesis Blocker-Induced Impairment of Early Phase.

Authors:  Alexander V Maltsev; Natalia V Bal; Pavel M Balaban
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.